Directions to overcome therapy resistance in cancer

dc.contributor.authorNussinov, Ruth
dc.contributor.authorWeichhart, Thomas
dc.contributor.authorDlamini, Zodwa
dc.contributor.authorGibbons, Don L.
dc.contributor.authorVan Seuningen, Isabelle
dc.contributor.authorKonen, Jessica
dc.contributor.authorJu, Huai-Qiang
dc.contributor.emailzodwa.dlamini@up.ac.zaen_US
dc.date.accessioned2024-12-11T12:46:02Z
dc.date.issued2024-06
dc.description.abstractNovel modalities for treatment of cancer have emerged because of advances in technology that have enabled expansion of our understanding of how cells transform to become cancerous and the role of the tumor microenvironment (TME). However, resistance to therapy poses a major problem for the successful treatment of cancer. Ongoing collaborative efforts of clinicians and researchers from different parts of the world have also led to an emerging understanding of how cancer cells evolve to resist treatment. Jerry Madukwe, the Editor-in-Chief of Trends in Pharmacological Sciences asked experts in the field to reflect on the global challenges in the cancer field and provide their views on what they see as the most pressing questions and research directions to overcome therapy resistance in cancer.en_US
dc.description.departmentMedical Oncologyen_US
dc.description.embargo2025-06-06
dc.description.librarianhj2024en_US
dc.description.sdgSDG-03:Good heatlh and well-beingen_US
dc.description.urihttps://www.sciencedirect.com/journal/trends-in-pharmacological-sciencesen_US
dc.identifier.citationNussinov, R., Weichhart, T., Dlamini, Z. et al. 2024, 'Directions to overcome therapy resistance in cancer', Trends in Pharmacological Sciences, vol. 45 no. 6, pp. 467-471, doi : 10.1016/j.tips.2024.05.001.en_US
dc.identifier.issn0165-6147 (print)
dc.identifier.issn1873-3735 (online)
dc.identifier.other10.1016/j.tips.2024.05.001
dc.identifier.urihttp://hdl.handle.net/2263/99889
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.rights© 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Notice : this is the author’s version of a work that was accepted for publication in Trends in Pharmacological Sciences. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in Trends in Pharmacological Sciences, vol. 45 no. 6, pp. 467-471, doi : 10.1016/j.tips.2024.05.001.en_US
dc.subjectCancer treatmenten_US
dc.subjectTumor microenvironment (TME)en_US
dc.subjectTherapy resistanceen_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.titleDirections to overcome therapy resistance in canceren_US
dc.typePostprint Articleen_US

Files

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: